Skip to content

Drug interactions

Imatinib + Momelotinib

Severity: Moderate

Imatinib and Momelotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Momelotinib inhibits BCRP and may increase exposure to BCRP substrates such as imatinib, which could increase imatinib adverse effects including cytopenias and fluid retention.

What this interaction means in plain words

Imatinib and Momelotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Momelotinib belongs to Oncology.

Evidence level: Low

Why it happens

Momelotinib inhibits BCRP, reducing imatinib efflux and increasing its exposure.

What to do

Monitor blood counts and signs of imatinib toxicity, and reduce the imatinib dose if adverse effects develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Momelotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Momelotinib?

MediHelp rates the interaction as moderate. Imatinib and Momelotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Momelotinib inhibits BCRP and may increase exposure to BCRP substrates such as imatinib, which could increase imatinib adverse effects including cytopenias and fluid retention.

How serious is the interaction between Imatinib and Momelotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and signs of imatinib toxicity, and reduce the imatinib dose if adverse effects develop.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in